Commission Implementing Decision (EU) 2021/2057 of 24 November 2021 establishing the equivalence, for the purpose of facilitating the right of free movement within the Union, of COVID-19 certificates issued by the Republic of Singapore to the certificates issued in accordance with Regulation (EU) 2021/953 of the European Parliament and of the Council (Text with EEA relevance)
Date: 2021-11-24
Institutions: Directorate-General for Justice and Consumers, European Commission
Subjects: Singapore, coronavirus disease, epidemic, free movement of persons, health certificate, health control, technical specification, vaccination








L_2021420EN.01012901.xml










25.11.2021   


EN


Official Journal of the European Union


L 420/129








            COMMISSION IMPLEMENTING DECISION (EU) 2021/2057
of 24 November 2021
         
establishing the equivalence, for the purpose of facilitating the right of free movement within the Union, of COVID-19 certificates issued by the Republic of Singapore to the certificates issued in accordance with Regulation (EU) 2021/953 of the European Parliament and of the Council
(Text with EEA relevance)


THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,


Having regard to Regulation (EU) 2021/953 of the European Parliament and of the Council of 14 June 2021 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic (1), and in particular Article 8(2) thereof,

Whereas:







(1)


Regulation (EU) 2021/953 lays down a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (‘EU Digital COVID Certificate’) for the purpose of facilitating the holders’ exercise of their right to free movement during the COVID-19 pandemic. It is also to contribute to facilitating the gradual lifting of restrictions to free movement put in place by Member States, in accordance with Union law, to limit the spread of SARS-CoV-2, in a coordinated manner.












(2)


Regulation (EU) 2021/953 allows for the acceptance of COVID-19 certificates issued by third countries to Union citizens and their family members where the Commission finds that those COVID-19 certificates are issued in accordance with standards that are to be considered as equivalent to those established pursuant to that Regulation. Furthermore, in accordance with Regulation (EU) 2021/954 of the European Parliament and of the Council (2), Member States are to apply the rules laid down in Regulation (EU) 2021/953 to third-country nationals who do not fall within the scope of that Regulation, but who are legally staying or residing in their territory and who are entitled to travel to other Member States in accordance with Union law. Therefore, any equivalence findings of this Decision should apply to COVID-19 vaccination and test certificates issued by the Republic of Singapore to Union citizens and their family members. Similarly, on the basis of Regulation (EU) 2021/954, such equivalence findings should also apply to COVID-19 vaccination and test certificates issued by the Republic of Singapore to third-country nationals legally staying or residing in the territory of the Member States under the conditions laid down in that Regulation.












(3)


On 26 July 2021, the Republic of Singapore provided the Commission with detailed information on the issuance of interoperable COVID-19 vaccination and test certificates under the system entitled ‘HealthCerts’. The Republic of Singapore informed the Commission that it considered that its COVID-19 certificates are being issued in accordance with a standard and a technological system that are interoperable with the trust framework established by Regulation (EU) 2021/953 and that allow for the verification of the authenticity, validity and integrity of the certificates. In this regard, the Republic of Singapore informed the Commission that COVID-19 certificates issued by the Republic of Singapore in accordance with the ‘HealthCerts’ system contain the data set out in the Annex to Regulation (EU) 2021/953.












(4)


The Republic of Singapore also informed the Commission that it accepts vaccination and test certificates issued by the Member States and EEA countries in accordance with Regulation (EU) 2021/953. In addition, the Republic of Singapore informed the Commission that it will treat holders of EU Digital COVID Certificate test and vaccination certificates equally as holders of test and vaccination certificates issued by the Republic of Singapore. In particular, the Republic of Singapore confirmed that the EU DCC test certificates will be accepted as valid proof of negative pre-departure test for travellers. The Republic of Singapore indicated that, following the adoption of this Decision, the holders of EU DCC vaccination certificates will be eligible for vaccination-differentiated safe management measures in Singapore for 30 days without additional vaccination certificates.












(5)


In particular, the Republic of Singapore informed the Commission that it recognises all vaccines having finalised the World Health Organisation’s Emergency Use Listing procedure as well as those authorised under Singapore’s Pandemic Special Access Route. Singapore will also accept PSAR-authorised vaccines. Regarding the tests, the Republic of Singapore informed the Commission that it accepts test certificates as proof of the traveller’s infection status, or lack thereof, but this currently does not translate into the waiving of travel restrictions. Those waivers are a matter of Singapore’s border health policies. Further, Singapore does not currently relax border requirements for recovered travellers.












(6)


On 30 September 2021, following a request by the Republic of Singapore, the Commission carried out technical tests that demonstrated that the COVID-19 vaccination and test certificates are issued by the Republic of Singapore in accordance with a system, the ‘HealthCerts’, that is interoperable with the trust framework established by Regulation (EU) 2021/953, and allows for the verification of the authenticity, validity and integrity of the certificates. The Commission also confirmed that the COVID-19 vaccination and test certificates issued by the Republic of Singapore in accordance with the ‘HealthCerts’ system contain the necessary data.












(7)


In addition, the Republic of Singapore informed the Commission that it will issue interoperable vaccination certificates for COVID-19 vaccines. Those vaccines currently include Comirnaty and Spikevax.












(8)


The Republic of Singapore also informed the Commission that it will issue interoperable test certificates only for nucleic acid amplification tests and for rapid antigen tests listed in the common and updated list of COVID-19 rapid antigen tests agreed by the Health Security Committee, established by Article 17 of Decision No 1082/2013/EU of the European Parliament and of the Council (3), on the basis of the Council Recommendation of 21 January 2021 (4).












(9)


Furthermore, the Republic of Singapore informed the Commission that it does not issue interoperable certificates of recovery.












(10)


In addition, the Republic of Singapore informed the Commission that when verifiers in Singapore verify certificates, the personal data included in them will be processed only to verify and confirm the holder’s vaccination, test result or recovery status and will not be retained afterwards.












(11)


The necessary elements for establishing that COVID-19 vaccination and test certificates issued by the Republic of Singapore in accordance with the ‘HealthCerts’ system are to be considered as equivalent to those issued in accordance with Regulation (EU) 2021/953 are thus fulfilled.












(12)


Therefore, COVID-19 certificates issued by the Republic of Singapore in accordance with the ‘HealthCerts’ system should be accepted under the conditions referred to in Articles 5(5) and 6(5) of Regulation (EU) 2021/953.












(13)


In order for this Decision to be operational, the Republic of Singapore should be connected to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953.












(14)


In order to protect the Union’s interests, in particular in the area of public health, the Commission may use its powers to suspend or terminate this Decision if the conditions of Article 8(2) of Regulation (EU) 2021/953 are no longer met.












(15)


In order to connect the Republic of Singapore to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953 as rapidly as possible, this Decision should enter into force on the day of its publication in the Official Journal of the European Union.












(16)


The measures provided for in this Decision are in accordance with the opinion of the Committee established by Article 14 of Regulation (EU) 2021/953,





HAS ADOPTED THIS DECISION:



Article 1
COVID-19 vaccination and test certificates issued by the Republic of Singapore in accordance with the ‘HealthCerts’ system shall, for the purpose of facilitating the right of free movement within the Union, be considered as equivalent to those issued in accordance with Regulation (EU) 2021/953.


Article 2
The Republic of Singapore shall be connected to the EU Digital COVID Certificate trust framework established by Regulation (EU) 2021/953.


Article 3
This Decision shall enter into force on the day of its publication in the Official Journal of the European Union.




Done at Brussels, 24 November 2021.


For the Commission


The President

Ursula VON DER LEYEN
            





(1)  
            OJ L 211, 15.6.2021, p. 1.

(2)  Regulation (EU) 2021/954 of the European Parliament and of the Council of 14 June 2021 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) with regard to third country nationals legally staying or residing in the territories of Member States during the COVID-19 pandemic (OJ L 211, 15.6.2021, p. 24).

(3)  Decision No 1082/2013/EU of the European Parliament and of the Council of 22 October 2013 on serious cross-border threats to health and repealing Decision No 2119/98/EC (OJ L 293, 5.11.2013, p. 1).

(4)  Council Recommendation of 21 January 2021 on a common framework for the use and validation of rapid antigen tests and the mutual recognition of COVID-19 test results in the EU (OJ C 24, 22.1.2021, p. 1).